Table 1.
Group description
| Feature | Details | |||
|---|---|---|---|---|
| Predictors | ||||
| Gender | Males: 74% (N = 237) | Females: 26% (N = 85) | ||
| EAU risk group | Low: 37% (N = 119) | Medium: 26% (N = 83) | High: 37% (N = 120) | |
| Age | Mean: 67.27 ± 11.14 years, Median: 68 years | |||
| Smoking | Nonsmokers: 70% (N = 224) | Smokers: 30% (N = 98) | ||
| T stage: | Ta: 63% (N = 203) | Tis: 3% (N = 9) | T1: 34% (N = 110) | |
| Grading | G1: 54% (N = 174) | G2: 35% (N = 113) | G3: 11% (N = 35) | |
| Number of tumors | Multiple: 36% (N = 115) | Single: 64% (N = 207) | ||
| Diameter | Less than 3 cm: 70% (N = 226) | 3 or more cm: 30% (N = 96) | ||
| Outcomes | ||||
| BCG treated | Yes: 29% (N = 92) | No: 71% (N = 230) | ||
| EORTC recurrence risk group | 1‐year 15%/5‐year 31% risk: 31% (N = 100) | 1‐year 24%/5‐year 26% risk: 37% (N = 119) | 1‐year 38%/5‐year 62% risk: 32% (N = 102) | 1‐year 61%/5‐year 78% risk: ~0% (N = 1) |
| EORTC progression risk group | 1‐year 0.2%/5‐year 0.8% risk: 39% (N = 125) | 1‐year 1%/5‐year 6% risk: 30% (N = 95) | 1‐year 17%/5‐year 45% risk: 4% (N = 14) | 1‐year 5%/5‐year 17% risk: 27% (N = 88) |
| CUETO recurrence risk group | 1‐year 8.2%/5‐year 21% risk: 76% (N = 244) | 1‐year 12%/5‐year 36% risk: 20% (N = 64) | 1‐year 25%/5‐year 48% risk: 4% (N = 12) | 1‐year 42%/5‐year 68% risk: 1% (N = 2) |
| CUETO progression risk group | 1‐year 1.2%/5‐year 3.7% risk: 77% (N = 247) | 1‐year 3%/5‐year 12% risk: 16% (N = 50) | 1‐year 5.5%/5‐year 21% risk: 8% (N = 25) | 1‐year 14%/5‐year 34% risk: 0% (N = 0) |
The table presents the general percentages of patients with partnonicular features, providing also the number of patients (N) with particular characteristics in our cohort.